share_log

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

4：持股變動聲明-高管 DOW GEOFFREY S
美股sec公告 ·  05/22 08:20
牛牛AI助理已提取核心訊息
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
60 Degrees Pharmicals總裁兼首席執行官傑弗裏·陶通過一系列交易完成了對公司85,000股普通股的收購。這些收購發生在2024年4月12日至2024年5月16日之間，價格從每股0.223美元到0.2668美元不等。這些交易之後，陶氏在該公司的直接持股量增加到762,625股。這些交易被報告爲衍生證券的行使或轉換，這表明該高管在公司的股份可能增加。
60 Degrees Pharmicals總裁兼首席執行官傑弗裏·陶通過一系列交易完成了對公司85,000股普通股的收購。這些收購發生在2024年4月12日至2024年5月16日之間，價格從每股0.223美元到0.2668美元不等。這些交易之後，陶氏在該公司的直接持股量增加到762,625股。這些交易被報告爲衍生證券的行使或轉換，這表明該高管在公司的股份可能增加。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。